Drugplain

BETULA LENTA POLLEN .1 g/mL

Birch Black · INJECTION, SOLUTION · ALK-Abello, Inc.

No Recall History
Plain English

BETULA LENTA POLLEN is a injection, solution containing birch black at .1 g/mL, taken subcutaneous. Manufactured by ALK-Abello, Inc..

Key Facts

Brand Name
BETULA LENTA POLLEN
Generic Name
Birch Black
NDC Code (Product)
0268-1056
Manufacturer
ALK-Abello, Inc.
Strength
.1 g/mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA103753
Marketing Start
01/01/1965

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Directions: FOR ORAL USE ONLY.

Dosage & Administration

Take 2 times daily. Ages 12 and older: 1-2 teaspoons. Ages 2-11: 1/2 teaspoon. Under age 2: Consult a doctor.

Warnings

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing. SHAKE WELL BEFORE USE. REFRIGERATE AFTER OPENING. BEST WHEN USED WITHIN 30 DAYS OF OPENING.

Frequently Asked Questions

What is BETULA LENTA POLLEN used for?

BETULA LENTA POLLEN contains Birch Black. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.

Is BETULA LENTA POLLEN a controlled substance?

BETULA LENTA POLLEN is not classified as a controlled substance by the DEA.

What is the generic name for BETULA LENTA POLLEN?

The generic name for BETULA LENTA POLLEN is Birch Black. There are no other listed brand versions of Birch Black.

What is the NDC code for BETULA LENTA POLLEN .1 g/mL?

The NDC (National Drug Code) for BETULA LENTA POLLEN .1 g/mL is 0268-1056, listed by ALK-Abello, Inc..

Product NDC

0268-1056

Package NDC

0268-1056-50

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)